EE03044B1 - Nukleosiidide diastereoselektiivse sünteesi protsess - Google Patents

Nukleosiidide diastereoselektiivse sünteesi protsess

Info

Publication number: EE03044B1
Authority: EE; Estonia
Prior art keywords: nucleosides; diastereoselective synthesis; diastereoselective; processes; synthesis
Prior art date: 1991-05-21

Application number

EE9400283A

Other languages

English (en)

Estonian (et)

Inventor

S. Mansour Tarek

Jin Haolun

H.L. Tse Allan

Arshad Siddiqui M.

Original Assignee

Biochem Pharma Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-21

Filing date

1994-10-20

Publication date

1997-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24825144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03044(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-20 Application filed by Biochem Pharma Inc. filed Critical Biochem Pharma Inc.

1997-10-15 Publication of EE03044B1 publication Critical patent/EE03044B1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Catalysts (AREA)
Furan Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

EE9400283A 1991-05-21 1994-10-20 Nukleosiidide diastereoselektiivse sünteesi protsess EE03044B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70337991A	1991-05-21	1991-05-21
PCT/CA1992/000211 WO1992020669A1 (en)	1991-05-21	1992-05-20	Processes for the diastereoselective synthesis of nucleosides

Publications (1)

Publication Number	Publication Date
EE03044B1 true EE03044B1 (et)	1997-10-15

Family

ID=24825144

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9400283A EE03044B1 (et)	1991-05-21	1994-10-20	Nukleosiidide diastereoselektiivse sünteesi protsess

Country Status (34)

Country	Link
US (5)	US5756706A (xx)
EP (2)	EP0515156B1 (xx)
JP (3)	JP3330972B2 (xx)
KR (3)	KR0160144B1 (xx)
CN (6)	CN1035555C (xx)
AT (2)	ATE157662T1 (xx)
AU (4)	AU1691392A (xx)
BG (2)	BG61695B1 (xx)
CA (2)	CA2069063C (xx)
CZ (3)	CZ280857B6 (xx)
DE (2)	DE69208144T2 (xx)
DK (2)	DK0515156T3 (xx)
EE (1)	EE03044B1 (xx)
ES (2)	ES2084937T3 (xx)
FI (3)	FI109025B (xx)
GR (2)	GR3018941T3 (xx)
GT (1)	GT199800047A (xx)
HK (1)	HK132196A (xx)
HU (2)	HU221850B1 (xx)
IE (2)	IE76741B1 (xx)
IL (6)	IL101931A (xx)
MD (1)	MD1155C2 (xx)
MX (2)	MX9202395A (xx)
NO (2)	NO301010B1 (xx)
NZ (2)	NZ242818A (xx)
OA (1)	OA10212A (xx)
PL (3)	PL176026B1 (xx)
RO (1)	RO116812B1 (xx)
RU (4)	RU2105009C1 (xx)
SG (1)	SG43863A1 (xx)
SK (2)	SK279438B6 (xx)
TW (4)	TW366349B (xx)
WO (2)	WO1992020696A1 (xx)
ZA (2)	ZA923640B (xx)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6903224B2 (en)	1988-04-11	2005-06-07	Biochem Pharma Inc.	Substituted 1,3-oxathiolanes
US6350753B1 (en)	1988-04-11	2002-02-26	Biochem Pharma Inc.	2-Substituted-4-substituted-1,3-dioxolanes and use thereof
US5684164A (en) *	1988-04-11	1997-11-04	Biochem Pharma Inc.	Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5466806A (en) *	1989-02-08	1995-11-14	Biochem Pharma Inc.	Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
EP0674634B1 (en) *	1989-02-08	2003-04-16	Biochem Pharma Inc	Process for preparing substituted 1,3-oxathiolanes with antiviral properties
US5827727A (en)	1990-02-01	1998-10-27	Emory University	Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5276151A (en) *	1990-02-01	1994-01-04	Emory University	Method of synthesis of 1,3-dioxolane nucleosides
US5204466A (en) *	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
US6703396B1 (en)	1990-02-01	2004-03-09	Emory University	Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
US5914331A (en) *	1990-02-01	1999-06-22	Emory University	Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5587480A (en) *	1990-11-13	1996-12-24	Biochem Pharma, Inc.	Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
US5444063A (en) *	1990-12-05	1995-08-22	Emory University	Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5925643A (en) *	1990-12-05	1999-07-20	Emory University	Enantiomerically pure β-D-dioxolane-nucleosides
US6812233B1 (en)	1991-03-06	2004-11-02	Emory University	Therapeutic nucleosides
US5817667A (en) *	1991-04-17	1998-10-06	University Of Georgia Research Foudation	Compounds and methods for the treatment of cancer
ZA923640B (en) *	1991-05-21	1993-02-24	Iaf Biochem Int	Processes for the diastereoselective synthesis of nucleosides
US6005107A (en) *	1992-12-23	1999-12-21	Biochem Pharma, Inc.	Antiviral compounds
US6444656B1 (en)	1992-12-23	2002-09-03	Biochem Pharma, Inc.	Antiviral phosphonate nucleotides
GB9226879D0 (en) *	1992-12-23	1993-02-17	Iaf Biochem Int	Anti-viral compounds
GB9226927D0 (en) *	1992-12-24	1993-02-17	Iaf Biochem Int	Dideoxy nucleoside analogues
US5627160A (en) *	1993-05-25	1997-05-06	Yale University	L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) *	1993-05-25	1999-11-11	Univ Yale	L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
GB9311709D0 (en) *	1993-06-07	1993-07-21	Iaf Biochem Int	Stereoselective synthesis of nucleoside analogues using bicycle intermediate
US20020120130A1 (en)	1993-09-10	2002-08-29	Gilles Gosselin	2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
CA2171550C (en)	1993-09-10	2008-08-26	Raymond F. Schinazi	Nucleosides with anti-hepatitis b virus activity
US5587362A (en) *	1994-01-28	1996-12-24	Univ. Of Ga Research Foundation	L-nucleosides
IL113432A (en) *	1994-04-23	2000-11-21	Glaxo Group Ltd	Process for the diastereoselective synthesis of nucleoside analogues
GB9413724D0 (en) *	1994-07-07	1994-08-24	Wellcome Found	Therapeutic nucleosides
US6448235B1 (en)	1994-07-11	2002-09-10	University Of Virginia Patent Foundation	Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en)	1994-07-11	2003-02-04	University Of Virginia Patent Foundation	Method compositions for treating the inflammatory response
IL115156A (en)	1994-09-06	2000-07-16	Univ Georgia	Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US6391859B1 (en)	1995-01-27	2002-05-21	Emory University	[5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en)	1995-01-27	1997-12-30	Emory University	Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5808040A (en) *	1995-01-30	1998-09-15	Yale University	L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US5869461A (en) *	1995-03-16	1999-02-09	Yale University	Reducing toxicity of L-nucleosides with D-nucleosides
GB9506644D0 (en) *	1995-03-31	1995-05-24	Wellcome Found	Preparation of nucleoside analogues
ATE346651T1 (de)	1995-06-07	2006-12-15	Univ Emory	Nucleoside mit anti-hepatitis b virus wirksamkeit
KR100213932B1 (ko) *	1995-11-02	1999-08-02	김충환	새로운 뉴클레오시드 유도체 및 그 제조방법
GB9600143D0 (en)	1996-01-05	1996-03-06	Wellcome Found	Therapeutic compounds
EP0799834A1 (en) *	1996-04-04	1997-10-08	Novartis AG	Modified nucleotides
US6005097A (en) *	1996-06-14	1999-12-21	Vion Pharmaceuticals, Inc.	Processes for high-yield diastereoselective synthesis of dideoxynucleosides
US5753789A (en) *	1996-07-26	1998-05-19	Yale University	Oligonucleotides containing L-nucleosides
US6022876A (en)	1996-11-15	2000-02-08	Yale University	L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections
CA2280761A1 (en)	1997-02-13	1998-08-20	Stanley Dawes Chamberlain	Benzimidazole derivatives
JP2001518899A (ja)	1997-04-07	2001-10-16	トライアングルファーマシューティカルズ，インコーポレイティド	他の抗ウイルス剤との組合せにおけるｍｋｃ−４４２の使用
DK0994890T3 (da)	1997-06-10	2003-12-01	Univ Michigan	Benzimidazolderivater
PL338454A1 (en)	1997-07-30	2000-11-06	Univ Michigan	Lixofuranosilbenzimidazoles as antiviral agents
US20030220234A1 (en) *	1998-11-02	2003-11-27	Selvaraj Naicker	Deuterated cyclosporine analogs and their use as immunodulating agents
YU44900A (sh)	1998-01-31	2003-01-31	Glaxo Group Limited	Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
CN1141305C (zh)	1998-08-12	2004-03-10	三角药物公司	生产1,3-氧硫戊环核苷的方法
US6979561B1 (en)	1998-10-09	2005-12-27	Gilead Sciences, Inc.	Non-homogeneous systems for the resolution of enantiomeric mixtures
OA11741A (en)	1998-12-23	2005-05-13	Iaf Biochem Int	Antiviral nucleoside analogues.
US7635690B2 (en)	1999-01-22	2009-12-22	Emory University	HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7115584B2 (en)	1999-01-22	2006-10-03	Emory University	HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
US6232297B1 (en)	1999-02-01	2001-05-15	University Of Virginia Patent Foundation	Methods and compositions for treating inflammatory response
YU25500A (sh)	1999-05-11	2003-08-29	Pfizer Products Inc.	Postupak za sintezu analoga nukleozida
US6322771B1 (en)	1999-06-18	2001-11-27	University Of Virginia Patent Foundation	Induction of pharmacological stress with adenosine receptor agonists
DE60011637T2 (de) *	1999-09-24	2004-11-11	Shire Biochem Inc., Laval	Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen
AU1262001A (en)	1999-11-04	2001-05-14	Biochem Pharma Inc.	Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
US6436948B1 (en)	2000-03-03	2002-08-20	University Of Georgia Research Foundation Inc.	Method for the treatment of psoriasis and genital warts
CA2308559C (en) *	2000-05-16	2005-07-26	Brantford Chemicals Inc.	1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues
JP5105689B2 (ja)	2001-03-01	2012-12-26	ギリード・サイエンシズ・インコーポレーテッド	多形型および他の結晶型のシス−ｆｔｃ
CA2351049C (en)	2001-06-18	2007-03-13	Brantford Chemicals Inc.	Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
JP4514452B2 (ja) *	2001-10-01	2010-07-28	ユニバーシティオブバージニアパテントファウンデーション	Ａ２ａアゴニスト活性を有する２−プロピルアデノシン・アナログおよびその組成物
CN100334106C (zh) *	2001-10-19	2007-08-29	伊索泰克尼卡股份有限公司	环孢菌素类似物的合成
ITMI20012317A1 (it) *	2001-11-06	2003-05-06	Recordati Ind Chimica E Farma	Processo diastereoselettivo per la preparazione del'agente antivirale4-amino-1-(2r-idrossimetil-/1,3/ossatiolan-5s-i1)-1h-pirimidin-2-one
CN1620295A (zh) *	2001-12-14	2005-05-25	法玛塞特有限公司	制备用于合成抗病毒核苷的中间体
JP4441265B2 (ja)	2002-01-25	2010-03-31	シャーバイオケムインコーポレイティッド	ジオキソランヌクレオシド類似体の製造方法
US7365173B2 (en) *	2002-02-04	2008-04-29	American National Red Cross	Method for the production of pure virally inactivated butyrylcholinesterase
US6855821B2 (en)	2002-08-06	2005-02-15	Pharmasset, Ltd.	Processes for preparing 1,3-dioxolane nucleosides
US20040224917A1 (en)	2003-01-14	2004-11-11	Gilead Sciences, Inc.	Compositions and methods for combination antiviral therapy
ITMI20030578A1 (it) *	2003-03-24	2004-09-25	Clariant Lsm Italia Spa	Processo ed intermedi per la preparazione di emtricitabina
EP1720840B1 (en)	2004-02-03	2016-02-03	Emory University	Methods to manufacture 1,3-dioxolane nucleosides
CA2576826C (en) *	2004-08-02	2014-09-30	University Of Virginia Patent Foundation	2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US7442687B2 (en) *	2004-08-02	2008-10-28	The University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7576069B2 (en) *	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7970631B2 (en) *	2004-08-31	2011-06-28	Ethicon Endo-Surgery, Inc.	Medical effector system
US7250416B2 (en)	2005-03-11	2007-07-31	Supergen, Inc.	Azacytosine analogs and derivatives
RU2430919C2 (ru) *	2005-03-14	2011-10-10	Шайр Канада Инк.	Способы получения оптически активного цис-2-гидроксиметил-4-(цитозин-1'-ил)-1,3-оксатиолана или его фармацевтически приемлемых солей
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
TWI375560B (en)	2005-06-13	2012-11-01	Gilead Sciences Inc	Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
US7700567B2 (en)	2005-09-29	2010-04-20	Supergen, Inc.	Oligonucleotide analogues incorporating 5-aza-cytosine therein
WO2007077505A2 (en) *	2005-12-30	2007-07-12	Ranbaxy Laboratories Limited	Crystalline l-menthyl (2r, 5s)-5-(4-amino-5-fluoro-2-oxo-2h-pyrimidin-1-yl)[1, 3]oxathiolan-2-carboxylate and process for preparation thereof
WO2007120972A2 (en) *	2006-02-10	2007-10-25	University Of Virginia Patent Foundation	Method to treat sickle cell disease
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
CA2667891A1 (en) *	2006-10-30	2008-05-08	Lupin Limited	An improved process for the manufacture of lamivudine
JP2010540556A (ja)	2007-09-26	2010-12-24	マウントサイナイスクールオブメディシン	アザシチジン類似体およびその使用
CN101918416A (zh) *	2007-11-29	2010-12-15	兰贝克赛实验室有限公司	制备取代的1,3-氧硫杂环戊烷,尤其是拉米夫定的方法和中间体
AU2008331166B2 (en) *	2007-11-29	2013-10-10	Ranbaxy Laboratories Limited	Process for the preparation of substituted 1,3-oxathiolanes
US8350030B2 (en)	2007-12-07	2013-01-08	Matrix Laboratories Limited	Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
HRP20151357T1 (hr)	2008-05-02	2016-01-29	Gilead Sciences, Inc.	Upotreba äśestica äśvrstog nosaäśa kako bi se poboljšala procesabilnost farmaceutskog agensa
WO2010082128A1 (en)	2009-01-19	2010-07-22	Aurobindo Pharma Limited	Process for the preparation of cis-nucleoside derivative
EA021313B1 (ru)	2009-02-06	2015-05-29	Джилид Сайэнс, Инк.	Таблетки для комбинированной терапии
CA2786227A1 (en) *	2010-01-08	2011-07-14	Hetero Research Foundation	Improved process for nucleosides
NZ627827A (en)	2010-01-27	2016-02-26	Viiv Healthcare Co	Antiviral combinations involving (3s, 11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
WO2011095987A1 (en) *	2010-02-03	2011-08-11	Matrix Laboratories Ltd.	Novel process for the preparation of cis-nucleoside derivative
PL2542551T3 (pl)	2010-03-04	2015-01-30	Ranbaxy Laboratories Ltd	Sposób stereoselektywnego otrzymywania 5-fluoro-1-(2R,SS)-[2-(hydroksymetylo)-1,3-oksatiolan--5-ylo]cytozyny
EP2377862A1 (en)	2010-03-29	2011-10-19	Esteve Química, S.A.	Process for obtaining emtricitabine
WO2011141805A2 (en)	2010-05-14	2011-11-17	Lupin Limited	An improved process for the manufacture of lamivudine
WO2012062835A1 (en)	2010-11-12	2012-05-18	Glaxo Wellcome Manufacturing Pte Ltd	Novel pharmaceutical compositions
EP2739620A1 (en)	2011-08-05	2014-06-11	Lupin Limited	A stereoselective process for preparation of 1,3-oxathiolane nucleosides
BR112014004779B1 (pt)	2011-08-30	2022-01-18	Astex Pharmaceuticals, Inc	Formulações de derivados de decitabina, kit e processos relacionados
CN103242243B (zh) *	2013-01-08	2015-08-19	北京大学	一种碱基乙酸甘油醚酯分子,其化学合成方法及其在基因治疗领域的应用
CN103288806A (zh) *	2013-07-02	2013-09-11	山东大学	一种曲沙他滨的合成方法
MX2018000016A (es)	2015-07-02	2019-01-31	Otsuka Pharma Co Ltd	Composiciones farmaceuticas liofilizadas.
CN105037340B (zh) *	2015-07-14	2018-08-10	福建广生堂药业股份有限公司	一种拉米夫定关键中间体手性异构体杂质的制备方法
MX2020001233A (es)	2017-08-03	2020-07-20	Otsuka Pharma Co Ltd	Compuesto farmaceutico y metodos de purificacion del mismo.
CN120665607A (zh) *	2023-04-21	2025-09-19	中南大学	一种用于对映选择性反胶团萃取的手性表面活性剂

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2895965A (en)		1959-07-21		Process for the production of
FR1445013A (fr) *	1964-07-09	1966-07-08	Thomae Gmbh Dr K	Procédé pour fabriquer des nouveaux acides dioxolano-2-carboxyliques
DE2508312A1 (de) *	1975-02-24	1976-09-02	Schering Ag	Neues verfahren zur herstellung von nucleosiden
US4383114A (en) *	1977-02-09	1983-05-10	Regents Of The University Of Minnesota	Adenosine deaminase resistant antiviral purine arabinonucleosides
US4182718A (en)	1977-10-25	1980-01-08	Monsanto Company	1,3-Dioxolane and 1,3-dioxane polycarboxylates, and precursors thereof
US4212860A (en)	1978-11-08	1980-07-15	Schering Corporation	4-O-(2,3,5-Trideoxy-5-amino-α-D-pentofuranosyl)-6-O-aminoglycosyl-1,3-diaminocyclitois, methods for their preparation, pharmaceutical formulations thereof and their use as antibacterial agents
US4231945A (en) *	1978-11-08	1980-11-04	Schering Corporation	S-5-(Azidomethyl or aminomethyl)-2-lower-alkoxytetrahydrofurans
US4479942A (en) *	1981-08-10	1984-10-30	Fujisawa Pharmaceutical Co., Ltd.	Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
US4855304A (en) *	1985-01-10	1989-08-08	Repligen Corporation	Dinucleoside pyrophosphates and pyrophosphate homologs as plant antivirals
DK363987A (da) *	1986-08-08	1988-02-09	Hoffmann La Roche	Pyrimidinderivater
GB8621268D0 (en) *	1986-09-03	1986-10-08	Univ Strathclyde	Separation of substances
US4997818A (en) *	1987-09-21	1991-03-05	The University Hospital	Therapeutic method for selectively treating terminal deoxynucleotidyl transferase-positive neoplastic leukemias and lymphomas
SE8704298D0 (sv) *	1987-11-03	1987-11-03	Astra Ab	Compounds for use in therapy
US4908440A (en) *	1987-11-12	1990-03-13	Bristol Myers Company	2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
US4997926A (en) *	1987-11-18	1991-03-05	Scripps Clinic And Research Foundation	Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy
JPH022349A (ja) *	1988-02-17	1990-01-08	Takeda Chem Ind Ltd	ピリミジンアナログ耐性化遺伝子ｄｎａおよびその用途
US4904770A (en) *	1988-03-24	1990-02-27	Bristol-Myers Company	Production of 2',3'-dideoxy-2',3'-didehydronucleosides
NZ228645A (en) *	1988-04-11	1991-09-25	Iaf Biochem Int	1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5047407A (en) *	1989-02-08	1991-09-10	Iaf Biochem International, Inc.	2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
DE3823127A1 (de) *	1988-07-08	1990-01-11	Rheinische Braunkohlenw Ag	Vorrichtung und verfahren zur reinigung von abwasser
US4987224A (en) *	1988-08-02	1991-01-22	University Of Georgia Research Foundation, Inc.	Method of preparation of 2',3'-dideoxynucleosides
DE3827134A1 (de) *	1988-08-10	1990-03-15	Bayer Ag	Substituierte triazolyl- bzw. imidazolyl-hydroxyalkyldioxolane, verfahren zu ihrer herstellung und ihre verwendung als mikrobizide, oxiranyldioxolane, dioxolanylketone, oxiranylketone und (alpha)-halogenketone als zwischenprodukte und verfahren zu deren herstellung
US5075225A (en) *	1989-04-06	1991-12-24	The Texas A&M University System	Process for the enzymatic synthesis of nucleosides
NZ233197A (en) *	1989-04-13	1991-11-26	Richard Thomas Walker	Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions
NZ234534A (en) *	1989-07-17	1994-12-22	Univ Birmingham	Pyrimidine 4'-thionucleoside derivatives and their preparation; intermediates therefor
IE904378A1 (en) *	1989-12-20	1991-07-03	Abbott Lab	Analogs of oxetanyl purines and pyrimidines
US5204466A (en) *	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) *	1990-05-02	1990-06-27	Glaxo Group Ltd	Chemical compounds
GB9014090D0 (en) *	1990-06-25	1990-08-15	Zaadunie Bv	Improvements in or relating to organic compounds
WO1992010496A1 (en) *	1990-12-05	1992-06-25	University Of Georgia Research Foundation, Inc.	ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
NZ250842A (en) *	1991-02-22	1996-03-26	Univ Emory	Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc)
WO1992018517A1 (en) *	1991-04-17	1992-10-29	Yale University	Method of treating or preventing hepatitis b virus
GB9109506D0 (en) *	1991-05-02	1991-06-26	Wellcome Found	Therapeutic nucleosides
ZA923640B (en) *	1991-05-21	1993-02-24	Iaf Biochem Int	Processes for the diastereoselective synthesis of nucleosides

1992
- 1992-05-19 ZA ZA923640A patent/ZA923640B/xx unknown
- 1992-05-19 ZA ZA923641A patent/ZA923641B/xx unknown
- 1992-05-20 IL IL10193192A patent/IL101931A/en not_active IP Right Cessation
- 1992-05-20 CZ CZ932493A patent/CZ280857B6/cs not_active IP Right Cessation
- 1992-05-20 PL PL92309052A patent/PL176026B1/pl unknown
- 1992-05-20 CZ CZ962224A patent/CZ284975B6/cs not_active IP Right Cessation
- 1992-05-20 RU RU93058554A patent/RU2105009C1/ru not_active IP Right Cessation
- 1992-05-20 NO NO921988A patent/NO301010B1/no not_active IP Right Cessation
- 1992-05-20 NO NO921989A patent/NO300593B1/no unknown
- 1992-05-20 ES ES92304551T patent/ES2084937T3/es not_active Expired - Lifetime
- 1992-05-20 SG SG1996003228A patent/SG43863A1/en unknown
- 1992-05-20 WO PCT/CA1992/000209 patent/WO1992020696A1/en not_active Ceased
- 1992-05-20 AU AU16913/92A patent/AU1691392A/en not_active Abandoned
- 1992-05-20 PL PL92301339A patent/PL168910B1/pl not_active IP Right Cessation
- 1992-05-20 SK SK1293-93A patent/SK279438B6/sk not_active IP Right Cessation
- 1992-05-20 ES ES92304552T patent/ES2104832T3/es not_active Expired - Lifetime
- 1992-05-20 CA CA002069063A patent/CA2069063C/en not_active Expired - Lifetime
- 1992-05-20 KR KR1019920008507A patent/KR0160144B1/ko not_active Expired - Fee Related
- 1992-05-20 MD MD95-0172A patent/MD1155C2/ro unknown
- 1992-05-20 AU AU16394/92A patent/AU655973B2/en not_active Expired
- 1992-05-20 US US08/142,389 patent/US5756706A/en not_active Expired - Fee Related
- 1992-05-20 RU RU93058362A patent/RU2140925C1/ru active
- 1992-05-20 KR KR1019920008694A patent/KR100232012B1/ko not_active Expired - Lifetime
- 1992-05-20 IL IL11610992A patent/IL116109A/en not_active IP Right Cessation
- 1992-05-20 EP EP92304551A patent/EP0515156B1/en not_active Expired - Lifetime
- 1992-05-20 IL IL101932A patent/IL101932A/xx not_active IP Right Cessation
- 1992-05-20 AU AU16908/92A patent/AU1690892A/en not_active Abandoned
- 1992-05-20 IL IL116176A patent/IL116176A/en not_active IP Right Cessation
- 1992-05-20 RO RO93-01554A patent/RO116812B1/ro unknown
- 1992-05-20 CZ CZ932492A patent/CZ285220B6/cs not_active IP Right Cessation
- 1992-05-20 PL PL92301340A patent/PL170869B1/pl unknown
- 1992-05-20 SK SK1294-93A patent/SK281954B6/sk not_active IP Right Cessation
- 1992-05-20 AT AT92304552T patent/ATE157662T1/de active
- 1992-05-20 NZ NZ242818A patent/NZ242818A/en not_active IP Right Cessation
- 1992-05-20 NZ NZ242817A patent/NZ242817A/en not_active IP Right Cessation
- 1992-05-20 DE DE69208144T patent/DE69208144T2/de not_active Expired - Fee Related
- 1992-05-20 RU RU96119766/04A patent/RU2163909C2/ru not_active IP Right Cessation
- 1992-05-20 EP EP92304552A patent/EP0515157B1/en not_active Expired - Lifetime
- 1992-05-20 DK DK92304551.2T patent/DK0515156T3/da active
- 1992-05-20 DE DE69221936T patent/DE69221936T2/de not_active Expired - Lifetime
- 1992-05-20 WO PCT/CA1992/000211 patent/WO1992020669A1/en not_active Ceased
- 1992-05-20 AT AT92304551T patent/ATE133958T1/de not_active IP Right Cessation
- 1992-05-20 AU AU16395/92A patent/AU668086B2/en not_active Ceased
- 1992-05-20 HU HU9303297A patent/HU221850B1/hu active IP Right Grant
- 1992-05-20 CA CA002069024A patent/CA2069024C/en not_active Expired - Fee Related
- 1992-05-20 HU HU9303296A patent/HU223838B1/hu not_active IP Right Cessation
- 1992-05-20 DK DK92304552.0T patent/DK0515157T3/da active
- 1992-05-20 RU RU99115480/04A patent/RU2223960C2/ru active
- 1992-05-21 CN CN92103924A patent/CN1035555C/zh not_active Expired - Fee Related
- 1992-05-21 MX MX9202395A patent/MX9202395A/es unknown
- 1992-05-21 JP JP12916392A patent/JP3330972B2/ja not_active Expired - Fee Related
- 1992-05-21 CN CN92103921A patent/CN1038591C/zh not_active Expired - Lifetime
- 1992-05-21 US US08/142,387 patent/US5696254A/en not_active Expired - Lifetime
- 1992-05-21 MX MX9202404A patent/MX9202404A/es unknown
- 1992-05-21 JP JP12915592A patent/JP3229013B2/ja not_active Expired - Lifetime
- 1992-06-02 TW TW081104321A patent/TW366349B/zh not_active IP Right Cessation
- 1992-06-02 TW TW088109433A patent/TWI245046B/zh not_active IP Right Cessation
- 1992-06-02 TW TW081104323A patent/TW366350B/zh not_active IP Right Cessation
- 1992-06-02 TW TW088109374A patent/TW467907B/zh not_active IP Right Cessation
- 1992-07-01 IE IE921619A patent/IE76741B1/en not_active IP Right Cessation
- 1992-07-01 IE IE161892A patent/IE921618A1/en not_active IP Right Cessation
1993
- 1993-11-19 FI FI935150A patent/FI109025B/fi active
- 1993-11-19 FI FI935151A patent/FI106377B/fi not_active IP Right Cessation
- 1993-11-19 OA OA60440A patent/OA10212A/en unknown
- 1993-12-20 BG BG98310A patent/BG61695B1/bg unknown
- 1993-12-20 BG BG98311A patent/BG61696B1/bg unknown
1994
- 1994-10-20 EE EE9400283A patent/EE03044B1/xx unknown
1995
- 1995-03-10 CN CN95102412A patent/CN1050603C/zh not_active Expired - Lifetime
- 1995-06-05 US US08/464,960 patent/US5744596A/en not_active Expired - Fee Related
- 1995-06-05 US US08/460,856 patent/US5663320A/en not_active Expired - Lifetime
- 1995-06-05 US US08/464,317 patent/US5693787A/en not_active Expired - Lifetime
- 1995-11-23 IL IL11610995A patent/IL116109A0/xx unknown
- 1995-11-28 IL IL11617695A patent/IL116176A0/xx unknown
1996
- 1996-02-08 GR GR960400299T patent/GR3018941T3/el unknown
- 1996-07-18 HK HK132196A patent/HK132196A/en not_active IP Right Cessation
1997
- 1997-09-04 GR GR970400204T patent/GR3024617T3/el unknown
1998
- 1998-03-04 GT GT199800047A patent/GT199800047A/es unknown
- 1998-12-03 CN CN98122385A patent/CN1083450C/zh not_active Expired - Lifetime
- 1998-12-03 CN CN98122383A patent/CN1109030C/zh not_active Expired - Lifetime
- 1998-12-03 CN CN98122384A patent/CN1097049C/zh not_active Expired - Lifetime
1999
- 1999-07-12 KR KR1019990027976A patent/KR100242921B1/ko not_active Expired - Lifetime
2000
- 2000-08-29 FI FI20001900A patent/FI20001900L/fi unknown
2001
- 2001-05-07 JP JP2001136217A patent/JP3704055B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1992020669A1 (en)	1992-11-26
AU668086B2 (en)	1996-04-26
NO301010B1 (no)	1997-09-01
BG98310A (bg)	1994-01-03
HUT67471A (en)	1995-04-28
IL101931A (en)	1996-12-05
AU1690892A (en)	1992-12-30
RU2223960C2 (ru)	2004-02-20
ES2104832T3 (es)	1997-10-16
CN1229079A (zh)	1999-09-22
US5693787A (en)	1997-12-02
CN1083450C (zh)	2002-04-24
US5696254A (en)	1997-12-09
JP2001354667A (ja)	2001-12-25
PL176026B1 (pl)	1999-03-31
SK129493A3 (en)	1994-11-09
HK132196A (en)	1996-07-26
CN1067654A (zh)	1993-01-06
SG43863A1 (en)	1997-11-14
DE69208144D1 (de)	1996-03-21
MX9202404A (es)	1993-08-31
JP3229013B2 (ja)	2001-11-12
US5756706A (en)	1998-05-26
DE69208144T2 (de)	1996-09-05
RU2105009C1 (ru)	1998-02-20
TW366350B (en)	1999-08-11
PL170869B1 (pl)	1997-01-31
EP0515156A1 (en)	1992-11-25
ZA923640B (en)	1993-02-24
CN1229080A (zh)	1999-09-22
FI106377B (fi)	2001-01-31
AU1639492A (en)	1992-11-26
CN1097049C (zh)	2002-12-25
GT199800047A (es)	1999-08-26
FI935150L (fi)	1993-11-19
TW366349B (en)	1999-08-11
CN1038591C (zh)	1998-06-03
CA2069063C (en)	1997-07-15
HK1002431A1 (en)	1998-08-21
FI935151A0 (fi)	1993-11-19
TWI245046B (en)	2005-12-11
IL116109A (en)	1998-12-27
HU9303297D0 (en)	1994-03-28
FI20001900A7 (fi)	2000-08-29
EP0515157B1 (en)	1997-09-03
IL116176A0 (en)	1996-01-31
HUT67726A (en)	1995-04-28
KR920021575A (ko)	1992-12-18
MD950172A (en)	1996-08-30
WO1992020696A1 (en)	1992-11-26
AU1691392A (en)	1992-12-30
CZ222496A3 (cs)	1999-04-14
FI935150A0 (fi)	1993-11-19
DE69221936D1 (de)	1997-10-09
IL116109A0 (en)	1996-01-31
DK0515156T3 (da)	1996-06-17
JPH05186465A (ja)	1993-07-27
NO921989L (no)	1992-11-23
NZ242817A (en)	1995-03-28
IL101932A (en)	1997-04-15
CZ285220B6 (cs)	1999-06-16
KR920021576A (ko)	1992-12-18
NO300593B1 (no)	1997-06-23
CN1109030C (zh)	2003-05-21
CN1050603C (zh)	2000-03-22
ATE133958T1 (de)	1996-02-15
HU221850B1 (hu)	2003-02-28
CA2069024C (en)	1997-09-23
CZ284975B6 (cs)	1999-04-14
ATE157662T1 (de)	1997-09-15
BG61695B1 (bg)	1998-03-31
IE76741B1 (en)	1997-11-05
NO921988D0 (no)	1992-05-20
BG98311A (bg)	1994-08-30
MX9202395A (es)	1993-02-01
DE69221936T2 (de)	1998-01-02
FI20001900L (fi)	2000-08-29
PL168910B1 (pl)	1996-05-31
GR3024617T3 (en)	1997-12-31
TW467907B (en)	2001-12-11
IE921618A1 (en)	1992-12-02
CZ249293A3 (en)	1994-03-16
RU2140925C1 (ru)	1999-11-10
GR3018941T3 (en)	1996-05-31
NO921988L (no)	1992-11-23
US5744596A (en)	1998-04-28
SK281954B6 (sk)	2001-09-11
CN1067245A (zh)	1992-12-23
IE921619A1 (en)	1992-12-02
CN1229078A (zh)	1999-09-22
OA10212A (en)	1997-10-07
FI109025B (fi)	2002-05-15
IL101932A0 (en)	1992-12-30
HU223838B1 (hu)	2005-02-28
NO921989D0 (no)	1992-05-20
CN1116204A (zh)	1996-02-07
HU9303296D0 (en)	1994-03-28
KR0160144B1 (ko)	1998-11-16
JPH05186463A (ja)	1993-07-27
DK0515157T3 (da)	1997-09-29
KR100242921B1 (ko)	2000-03-15
RU2163909C2 (ru)	2001-03-10
CA2069024A1 (en)	1992-11-22
JP3704055B2 (ja)	2005-10-05
CZ249393A3 (en)	1994-04-13
IL101931A0 (en)	1992-12-30
KR100232012B1 (ko)	1999-12-01
MD1155B2 (en)	1999-02-28
FI935151L (fi)	1993-11-19
JP3330972B2 (ja)	2002-10-07
CN1035555C (zh)	1997-08-06
RO116812B1 (ro)	2001-06-29
AU655973B2 (en)	1995-01-19
SK279438B6 (sk)	1998-11-04
ZA923641B (en)	1993-02-24
CZ280857B6 (cs)	1996-04-17
IL116176A (en)	1998-02-08
SK129393A3 (en)	1994-07-06
US5663320A (en)	1997-09-02
CA2069063A1 (en)	1992-11-22
AU1639592A (en)	1992-11-26
BG61696B1 (bg)	1998-03-31
ES2084937T3 (es)	1996-05-16
EP0515157A1 (en)	1992-11-25
NZ242818A (en)	1994-04-27
MD1155C2 (ro)	1999-10-31
EP0515156B1 (en)	1996-02-07

Publication	Publication Date	Title
EE03044B1 (et)	1997-10-15	Nukleosiidide diastereoselektiivse sünteesi protsess
RU93058554A (ru)	1996-12-27	Способы диастереоселективного синтеза нуклеозидов
RU93058362A (ru)	1997-01-20	Способы диастереоселективного синтеза нуклеозидов, промежуточные соединения, способы получения промежуточных соединений
FI101793B1 (fi)	1998-08-31	Menetelmä uusien, terapeuttisesti käyttökelpoisten 9-purinyylifosfonihappojohdannaisten valmistamiseksi
PT97478A (pt)	1992-01-31	Processo de producao de derivados n-(3-fluoro-2-fosfonilmetoxipropilo) de bases puricas e pirimidicas heterociclicas e de composicoes farmaceuticas que os contem
DK1091001T3 (da)	2005-11-14	Fremgangsmåde til rensning af S-adenosyl-L-methionin og til fremstilling af farmaceutiske acceptable salte deraf
NO974512L (no)	1997-09-29	Fremgangsmåte for syntese av nukleosid-analoger
FI960286L (fi)	1996-01-19	Välituotteita nukleosidien diastereoselektiivisiin synteesimenetelmiin
IT8721511A0 (it)	1987-07-30	Processo per la produzione di atenololo elevata purezza

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2006-12-15	HC1A	Change of owner name
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2008-08-15	HC1A	Change of owner name
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231